-
Liproxstatin-1 HCl: Ferroptosis Assay Workflows
2026-09-03
Liproxstatin-1 HCl provides a selective rescue tool for separating ferroptotic lipid damage from apoptosis and nonspecific oxidative toxicity. This practical guide covers assay design, stock preparation, mechanistic controls, translational injury models, and troubleshooting for more reproducible ferroptosis research.
-
IWP-2 and Cell-State-Aware Wnt Assays
2026-09-02
IWP-2 is a potent Wnt production inhibitor for dissecting ligand-dependent Wnt signaling pathway activity. This article connects PORCN pharmacology with cell-state-aware assay design, showing how epigenetic and cell-type considerations can improve interpretation in cancer research without overstating pathway causality.
-
Ertapenem Sodium Salt for Resistance Research
2026-09-02
Ertapenem sodium salt provides a practical phenotypic anchor for MIC testing, resistance selection, and carbapenemase-transmission studies. This workflow connects reproducible compound handling with plasmid localization, conjugation, and strain-level epidemiology while keeping clinical interpretation appropriately separate.
-
RIPK1 and IL-8 Biomarkers in ALS: Primidone Study
2026-09-01
Wei and colleagues link elevated peripheral RIPK1 and IL-8 with amyotrophic lateral sclerosis (ALS), and show that Primidone treatment reduces both markers in a translational mouse–human study. The work supports serum RIPK1 and IL-8 as candidate pharmacodynamic biomarkers while providing a rationale for evaluating Primidone as a repurposed RIPK1 inhibitor, although biomarker reduction does not by itself establish clinical efficacy.
-
Mycophenolic Acid in Whole-Blood Assays
2026-09-01
Use Mycophenolic acid as a controlled dehydrogenase inhibitor to connect nucleotide metabolism with cytokine responses in fresh whole-blood stimulation assays. This workflow emphasizes solvent control, donor-aware design, rapid solution handling, and practical troubleshooting for immunometabolism and anti-infection research.
-
Multiomics Reveals Bifendate Mechanisms in Liver Injury
2026-08-31
The reference study combines co-expression network analysis with transcriptomic and proteomic profiling to examine how Bifendate and muaddil sapra act in CCl4-induced acute liver injury. Its main contribution is a systems-level comparison showing that the two treatments influence overlapping injury modules through partly distinct non-coding RNA, transcription-factor, and protein-associated mechanisms.
-
H. pylori, p38 MAPK, and IL-8 in Pediatric Airways
2026-08-31
The reference study established a primary rhesus airway epithelial model showing that Helicobacter pylori preferentially induces IL-8 through its cag type IV secretion system and p38 MAP kinase. Its limited response to JSH-23 indicates that NF-κB inhibition alone does not necessarily suppress pathogen-driven cytokine production in pediatric airway epithelium.
-
Tunicamycin as a Precision ER Stress Comparator
2026-08-30
Tunicamycin is more than an N-glycosylation inhibitor: it is a defined comparator for separating general ER stress from stimulus-specific unfolded protein responses. This guide connects Tunicamycin assay design with new HAX1–SARS-CoV-2 spike findings and practical macrophage workflows.
-
A-769662: AMPK Activation Beyond Autophagy
2026-08-29
A-769662 is a reversible AMPK activator for dissecting energy metabolism, autophagy, and proteasome biology. This evidence-focused guide explains why AMPK activation does not always increase autophagy and how to design assays that separate pathway effects from compound-specific mechanisms.
-
Streptavidin-Cy3 Workflows for NPC Metastasis
2026-08-28
Build sensitive IHC, ISH, IF, and flow cytometry assays around a high-affinity streptavidin cy3 conjugate. This guide connects biotin-based detection to super-enhancer RNA and NDRG1 studies in nasopharyngeal carcinoma while emphasizing controls, optimization, and interpretation limits.
-
HyperScript III RT SuperMix for CRC RNA Stratification
2026-08-28
HyperScript III RT SuperMix supports reproducible gene expression analysis by qPCR when colorectal cancer RNA is scarce, GC-rich, or vulnerable to genomic DNA carryover. This article translates bile acid metabolism-based CRC findings into a practical assay-design and validation framework.
-
GSK343: Reliable EZH2 Assay Workflows
2026-08-27
Learn how GSK343 (SKU A3449) can improve the interpretation of cell viability, proliferation, and H3K27me3 assays through careful solvent control, concentration planning, and orthogonal validation. This scenario-based guide distinguishes biochemical potency from cellular response and defines practical limits for epigenetic cancer research.
-
Filipin III for Cholesterol Assay Design
2026-08-27
Filipin III provides a spatial view of membrane-associated cholesterol that can sharpen interpretation of macrophage lipid dysregulation. This guide connects cholesterol detection in membranes with SOAT1-driven lipophagy failure and pulmonary fibrosis research while defining practical controls and limitations.
-
Ozone, Efferocytosis, and Neuropathic Pain
2026-08-26
A 2024 Frontiers in Immunology study identifies macrophage efferocytosis as a modifiable component of neuropathic pain and links ozone treatment to the AMPK/Gas6-MerTK/SOCS3 pathway. In chronic constriction injury mice and bone-marrow-derived macrophages, ozone improved apoptotic-cell clearance, reduced inflammatory signaling, and alleviated mechanical hypersensitivity, while pharmacological pathway inhibition weakened these effects.
-
Fluoroalkane Polymers for mRNA Cancer Vaccines
2026-08-26
The reference study introduces fluoroalkane-grafted polyethylenimine (F-PEI) as a relatively simple carrier for therapeutic mRNA. Its self-assembled nanovaccines improved intracellular delivery, promoted TLR4-associated dendritic-cell activation and antigen presentation, and produced antitumor activity in ovalbumin and neoantigen mouse models, particularly when combined with immune checkpoint blockade.